Skip to main content
. 2021 Feb 2;35(6):1548–1550. doi: 10.1038/s41433-020-01324-w

Fig. 1.

Fig. 1

Avoiding Brolucizumab Related Adverse Event by Scrutinizing Available Evidence (A BRAVE-SAVE) Recommendation. OCT Optical coherence tomography, IVFA Intravenous fluorescein angiography.